Literature DB >> 2850196

Comparison of three paf-acether receptor antagonist ginkgolides.

R Korth1, D Nunez, J Bidault, J Benveniste.   

Abstract

The aggregation of washed human platelets with paf-acether (paf) and [3H]paf binding were inhibited in a concentration- and time-dependent manner by three chemically defined ginkgolides (BN 52020, BN 52021, BN 52022) and their mixture, BN 52063 (molar ratio: 2:2:1). The IC50 values for aggregation correlated well with the IC50 values for [3H]paf binding (R-square 0.971). BN 52021, BN 52020 and BN 52063 (6 microM), as well as unlabelled paf (50 nM), displaced platelet-bound [3H]paf. Specific binding (total minus non-specific binding) in the presence of BN 52020 and BN 52063 was saturated but that observed in the presence of BN 52022 was not. However all ginkgolides shifted the dose-dependent paf-induced platelet aggregation curve rightwards. BN 52063 failed to modulate paf metabolism either in plasma or in the presence of platelets. The present results suggest that the ginkgolide mixture, BN 52063, acts at the paf binding level and the close correlation between ginkgolide effects on aggregation vs. paf binding illustrates the functional relevance of the putative paf platelet receptor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850196     DOI: 10.1016/0014-2999(88)90840-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Simultaneous determination by UPLC-MS/MS of seven bioactive compounds in rat plasma after oral administration of Ginkgo biloba tablets: application to a pharmacokinetic study.

Authors:  Wen-ping Wang; Na Liu; Qian Kang; Pei-pei Du; Yi Lan; Bo-chen Zhao; Yan-yan Chen; Qing Zhang; Hui Li; Ye-wen Zhang; Qing Wu
Journal:  J Zhejiang Univ Sci B       Date:  2014-11       Impact factor: 3.066

2.  The effect of inhibitors of platelet aggregation on the metabolism of platelet-activating factor (PAF) in washed rabbit platelets.

Authors:  C O'Neill; A J Ammit; R Korth; S Fleming; X Wells
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  Platelet alpha2-adrenoceptor alterations in patients with essential hypertension.

Authors:  K Varani; S Gessi; A Caiazza; G Rastelli; F Portaluppi; P A Borea
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

Review 4.  Ginkgo biloba for intermittent claudication.

Authors:  Saskia P A Nicolaï; Lotte M Kruidenier; Bianca L W Bendermacher; Martin H Prins; Rutger A Stokmans; Pieter P H L Broos; Joep A W Teijink
Journal:  Cochrane Database Syst Rev       Date:  2013-06-06

5.  Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.

Authors:  R Korth; M Hirafuji; C L Keraly; D Delautier; J Bidault; J Benveniste
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

6.  Human platelets release a paf-acether: acetylhydrolase similar to that in plasma.

Authors:  R Korth; J Bidault; R Palmantier; J Benveniste; E Ninio
Journal:  Lipids       Date:  1993-03       Impact factor: 1.880

7.  Pharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]-CGS 21680 binding.

Authors:  K Varani; S Gessi; A Dalpiaz; P A Borea
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

8.  The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation.

Authors:  Jia Ke; Meng-Ting Li; Ya-Jing Huo; Yan-Qiong Cheng; Shu-Fen Guo; Yang Wu; Lei Zhang; Jianpeng Ma; Ai-Jun Liu; Yan Han
Journal:  Drug Des Devel Ther       Date:  2021-08-14       Impact factor: 4.162

9.  Ginkgolide B inhibits the neurotoxicity of prions or amyloid-beta1-42.

Authors:  Clive Bate; Mario Salmona; Alun Williams
Journal:  J Neuroinflammation       Date:  2004-05-11       Impact factor: 8.322

10.  Ginkgolides protect against amyloid-beta1-42-mediated synapse damage in vitro.

Authors:  Clive Bate; Mourad Tayebi; Alun Williams
Journal:  Mol Neurodegener       Date:  2008-01-07       Impact factor: 14.195

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.